Talis Biomedical Corp (TLIS)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Talis Biomedical Corp-Aktie (TLIS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	62.56% 0.073	0.195	0.14	0.581	1.218
Cost Of Revenue	25.00% 0.006	0.008	0.006	0.007	0.02
Gross Profit	64.17% 0.067	0.187	0.134	0.574	1.198
Operating Expenses	3.13% 14.18	14.64	17.11	16.96	20.20
Benefits Costs and Expenses	4.01% 13.11	13.65	17.11	16.97	19.05
Costs And Expenses	3.15% 14.19	14.65	17.11	16.97	20.21
Depreciation and Amortization	24.17% 0.262	0.211	0.217	0.168	0.174
Operating Income/Loss	2.35% -14.12	-14.46	-16.97	-16.39	-19.00
Income/Loss From Continuing Operations Before Tax	3.16% -13.04	-13.46	-16.97	-15.03	-17.83
Income/Loss From Continuing Operations After Tax	3.16% -13.04	-13.46	-15.68	-15.03	-17.83
Net Income/Loss	3.16% -13.04	-13.46	-15.68	-15.03	-17.83
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	150.23K% 1.8221	0.00121	1.8191	1.8173	26.82
Diluted Average Shares	150.23K% 1.8221	0.00121	1.8191	1.8173	26.82
Basic Earnings Per Share	3.25% -7.15	-7.39	-8.62	-8.27	-0.66
Diluted Earnings Per Share	3.25% -7.15	-7.39	-8.62	-8.27	-0.66
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

STE

$217.09

1.38%

ZBH

$113.02

0.43%

PHG

$25.95

0.43%

DXCM

$76.27

0.51%

GEHC

$82.72

1.17%

$69.89

3.14%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Offen in Reuters